Botanic Healthcare has announced clinical results for its next-generation liposomal iron ingredient, IRONNOX® (Liposomal Ferric Pyrophosphate).
In a randomised, active-controlled, 56-day clinical study involving 60 women with irondeficiency anaemia, IRONNOX® demonstrated greater improvements in key iron-status parameters compared with conventional ferric pyrophosphate. By Day 56, haemoglobin levels were 7.2% higher, while serum ferritin was 41.8% higher in the IRONNOX® group. Transferrin saturation was also 18.8% higher, alongside an 18% lower fatigue score.
Notably, no gastrointestinal-related adverse events were reported in the IRONNOX® group, compared with 20% in the conventional ferric pyrophosphate group.
“Iron supplementation should not be a compromise between efficacy and tolerability. Our clinical findings with IRONNOX® demonstrate the potential of advanced delivery technology to improve key markers of iron status while maintaining favourable gastrointestinal tolerability,” said Gaurav Soni, Managing Director, Botanic Healthcare.
Madhu Krishnamani, Managing Director, Botanic Healthcare, added: “These results strengthen our commitment to developing clinically researched nutritional ingredients that address important challenges in iron supplementation.”
Dr. Shiv, Chief Scientific Officer, Botanic Healthcare, said: “The clinical findings demonstrate improvements across key markers of iron status, supporting the potential of liposomal delivery for iron supplementation. The study, led by Dr. Sravani and the clinical research team, provided important evidence supporting the performance of liposomal ferric pyrophosphate. Our Caco-2 permeability data demonstrated 2.1-fold higher permeability for liposomal ferric pyrophosphate compared with conventional ferric pyrophosphate, providing additional invitro supporting evidence for the liposomal delivery approach.”
The findings add to Botanic Healthcare’s growing focus on clinically researched delivery technologies designed to support the performance and user experience of nutritional ingredients.
About IRONNOX®
IRONNOX® is Botanic Healthcare’s liposomal ferric pyrophosphate (FPP) ingredient, developed using patent-filed DFS Technology™. It is designed to support efficient iron delivery while maintaining favourable gastrointestinal tolerability.
IRONNOX® has been evaluated in a randomized, active-controlled clinical study in women with iron-deficiency anaemia, providing clinical evidence for its performance as a next-generation iron delivery ingredient.
About Botanic Healthcare
Botanic Healthcare is a research-driven ingredient company focused on developing innovative, science-backed botanical and nutraceutical ingredients. The company combines proprietary technologies, formulation expertise, and clinical research to develop differentiated ingredients for global nutrition and wellness applications.
Its LipsoBio® platform focuses on advanced liposomal delivery systems designed to support the delivery and performance of nutritional actives.
Visit www.botanichealthcare.com & www.lipsobio.com for more information.
For Media Enquires:
Harrish Posa
DGM Marketing
branding@botanichealthcare.com

















